KOSPI30 Market Intelligence

Publication-safe Korean KOSPI30 market brief
한국어English日本語
staging review
Data trust status Information only
Snapshot
2026-06-04
Data as of
2026-06-04
News as of
2026-06-04 18:34:00 KST
Hidden sections
watchlist hidden
Stocks / 삼성바이오로직스
Stock detail207940
Price
1,350,000
2026-06-04
1-day return
-1.24%
Price change
5-day return
-2.46%
Price change
Matched headlines
22
2026-06-04 18:12:00 KST
Publication status
Review required
market brief only
Related headlines
1
source headlines only
This page shows public-safe price metrics, headline matches, disclosure counts, and catalyst status aggregates only.
Stock contextWarning
Active catalyst
2
Catalyst status
Watch catalyst
10
Catalyst status
Recent disclosures
5
2026-06-01 09:00:00 KST
Catalyst strength
0.8200
capacity_investment, earnings_update, industry_m
When model or audit gates are in warning state, watchlists are hidden and only the market brief is published.
Service sectionsstaging
Free brief
Market summary, issue stocks, and public headlines
Planned
Ad-supported deep dive
Stock context and additional public-safe history
Planned
Premium archive
Performance validation, long-term tracking, and alert-style research
Planned
Ad slot
Reserved for activation after external deployment and advertising-policy review.
Planned
Reader updates
Newsletter or alert opt-in can be enabled after privacy-policy review.
Privacy review pending
Latest contextsource headlines only
FSS Reduces Fine for Banking Sector's Hong Kong ELS to Hundreds of BillionsSource
The Financial Supervisory Service significantly lowered the fine amount related to the improper sale of Hong Kong H-index Equity Linked Securities (ELS). This follows a period where the Financial Services Commission officially rejected major disciplinary measures from the FSS, such as after the Samsung Biologics accounting scandal in 2018.
This suggests regulatory adjustments regarding complex financial products like ELSs sold by banks.
naver_news · 2026-06-04 18:12:00 KST · 삼성바이오로직스 · gemma4:e4b